Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05203692 · ClinicalTrials.gov registry record · Phase 1

A Study of a Single Ascending Dose Study of DS-7011a in Healthy Subjects

A Phase 1 study of Systemic Lupus Erythematosus, sponsored by Daiichi Sankyo.

Completed
Registry status
Phase 1
Development phase
80
Enrollment target
2
Study locations

NCT05203692 is a Phase 1 study of Systemic Lupus Erythematosus that has completed, run by Daiichi Sankyo. The registered enrollment target is 80 participants, below the 380-participant average among 99 other Systemic Lupus Erythematosus trials with a reported enrollment target (79% lower). The trial reports 2 study locations across 2 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05203692, a Phase 1 study of Systemic Lupus Erythematosus, has completed, sponsored by Daiichi Sankyo.

COMPLETED
Registry status
Phase 1
Development phase
80 participants
Enrollment target
2
Study locations

Study Summary

This will be the first-in-human study designed to evaluate the safety, pharmacokinetics (PK), and pharmacodynamics (PD) of single ascending doses of DS-7011a in healthy participants.

Conditions Studied

Systemic Lupus Erythematosus

Interventions

  • DRUG Placebo
  • DRUG DS-7011a

Study Locations (2)

California

  • Apex Clinical Research (Collaborative Neuroscience Research) - Long Beach

Texas

  • Worldwide Clinical Trials - San Antonio

Trial Details

FieldValue
Enrollment Target 80 participants
Start Date 2022-02-02
Est. Completion 2023-03-22
Phase Phase 1

Sponsor

Daiichi Sankyo

236 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT05203692

The ClinicalTrials.gov registry entry for NCT05203692 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 80 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 380-participant average among 99 other Systemic Lupus Erythematosus trials with a reported enrollment target (79% lower). The listed sponsor is Daiichi Sankyo, which has 236 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Systemic Lupus Erythematosus appearing as the primary indexed condition, and to 2 interventions - of which Placebo is the first listed.

NCT05203692 reports 2 study locations spanning 2 distinct geographic areas - top geographies include California, Texas.

Frequently Asked Questions

What is clinical trial NCT05203692 about?

NCT05203692 is a clinical study titled "A Study of a Single Ascending Dose Study of DS-7011a in Healthy Subjects". This will be the first-in-human study designed to evaluate the safety, pharmacokinetics (PK), and pharmacodynamics (PD) of single ascending doses of DS-7011a in healthy participants.

What is the current status of trial NCT05203692?

This trial is currently completed. It is a Phase 1 study. The enrollment target is 80 participants. The study started on 2022-02-02. Estimated completion is 2023-03-22.

What conditions does trial NCT05203692 study?

This clinical trial studies the following conditions: Systemic Lupus Erythematosus.

What interventions are being tested in trial NCT05203692?

The interventions under investigation include: Placebo (DRUG), DS-7011a (DRUG).

Who is sponsoring clinical trial NCT05203692?

This trial is sponsored by Daiichi Sankyo, which has 236 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05203692 being conducted?

This trial has 2 study locations across California, Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Systemic Lupus Erythematosus

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Systemic Lupus Erythematosus

All registered trials for this condition

California

All trials with a study site in California

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.